
NYSEHealthcareMedical - Diagnostics & Research
Latest quote
$404.81
+$1.90 · +0.47%
Waters Corporation is a global leader in specialized measurement, delivering analytical solutions across Asia, the Americas, and Europe. The company operates through two main divisions: Waters and TA. Under its Waters segment, it engineers, manufactures, sells, and provides support for high and ultra-performance liquid chromatography and mass spectrometry (MS) systems. This includes essential consumables like chromatography columns and comprehensive post-warranty service plans. The TA segment focuses on designing, producing, selling, and servicing instruments for thermal analysis, rheometry, and calorimetry. Additionally, Waters develops and supplies sophisticated software that integrates with both its own instruments and those from other manufacturers. The company's advanced MS technology plays a crucial role in various applications, such as drug discovery and development (including clinical trial assessments), analyzing proteins involved in disease processes, ensuring nutritional safety, and conducting environmental testing. Its thermal analysis, rheometry, and calorimetry instruments are vital for assessing the suitability and stability of a wide range of materials, including fine chemicals, pharmaceuticals, water, polymers, metals, and viscous liquids. These instruments support diverse sectors like industrial manufacturing, consumer goods, healthcare products, and life science research. Waters' extensive client base spans the life sciences, pharmaceutical, biochemical, industrial, nutritional safety, environmental, academic, and governmental sectors, where its products are instrumental in research and development, quality assurance, and general laboratory operations. Established in 1958, Waters Corporation is headquartered in Milford, Massachusetts.
Latest quote
$404.81
+$1.90 · +0.47%
After-hours
$404.81
$0.00 · 0.00%
Sep 9, 5:26 PM ET
Regular session · ET · Market data may be delayed.
Waters Corporation is a global leader in specialized measurement, delivering analytical solutions across Asia, the Americas, and Europe. The company operates through two main divisions: Waters and TA. Under its Waters segment, it engineers, manufactures, sells, and provides support for high and ultra-performance liquid chromatography and mass spectrometry (MS) systems. This includes essential consumables like chromatography columns and comprehensive post-warranty service plans. The TA segment focuses on designing, producing, selling, and servicing instruments for thermal analysis, rheometry, and calorimetry. Additionally, Waters develops and supplies sophisticated software that integrates with both its own instruments and those from other manufacturers. The company's advanced MS technology plays a crucial role in various applications, such as drug discovery and development (including clinical trial assessments), analyzing proteins involved in disease processes, ensuring nutritional safety, and conducting environmental testing. Its thermal analysis, rheometry, and calorimetry instruments are vital for assessing the suitability and stability of a wide range of materials, including fine chemicals, pharmaceuticals, water, polymers, metals, and viscous liquids. These instruments support diverse sectors like industrial manufacturing, consumer goods, healthcare products, and life science research. Waters' extensive client base spans the life sciences, pharmaceutical, biochemical, industrial, nutritional safety, environmental, academic, and governmental sectors, where its products are instrumental in research and development, quality assurance, and general laboratory operations. Established in 1958, Waters Corporation is headquartered in Milford, Massachusetts.
Day range
Current $404.81
52-week range
Current $404.81
Regular session · ET · Market data may be delayed.
GoAI Score
Hold
Valuation
41
Fair Value
Sentiment
70
Bullish
Risk
31
Moderate Risk
Momentum
46
Neutral
Full GoAI research
Thesis, catalysts, evidence, and risk analysis.
Waters Corporation is a global leader in specialized measurement, delivering analytical solutions across Asia, the Americas, and Europe. The company operates through two main divisions: Waters and TA. Under its Waters segment, it engineers, manufactures, sells, and provides support for high and ultra-performance liquid chromatography and mass spectrometry (MS) systems. This includes essential consumables like chromatography columns and comprehensive post-warranty service plans. The TA segment focuses on designing, producing, selling, and servicing instruments for thermal analysis, rheometry, and calorimetry. Additionally, Waters develops and supplies sophisticated software that integrates with both its own instruments and those from other manufacturers. The company's advanced MS technology plays a crucial role in various applications, such as drug discovery and development (including clinical trial assessments), analyzing proteins involved in disease processes, ensuring nutritional safety, and conducting environmental testing. Its thermal analysis, rheometry, and calorimetry instruments are vital for assessing the suitability and stability of a wide range of materials, including fine chemicals, pharmaceuticals, water, polymers, metals, and viscous liquids. These instruments support diverse sectors like industrial manufacturing, consumer goods, healthcare products, and life science research. Waters' extensive client base spans the life sciences, pharmaceutical, biochemical, industrial, nutritional safety, environmental, academic, and governmental sectors, where its products are instrumental in research and development, quality assurance, and general laboratory operations. Established in 1958, Waters Corporation is headquartered in Milford, Massachusetts.
Day range
Current $404.81
52-week range
Current $404.81
Profitability as a percentage of reported revenue.
Revenue
Operating income
Net income
| Metric (USD) | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 3.17B USD | 2.96B USD | 2.96B USD | 2.97B USD | 2.79B USD |
| Cost of goods sold | 1.34B USD | 1.2B USD | 1.2B USD | 1.25B USD | 1.16B USD |
| Gross profit | 1.83B USD | 1.76B USD | 1.76B USD | 1.72B USD | 1.63B USD |
| Research and development | 195.18M USD | 183.03M USD | 174.95M USD | 176.19M USD | 168.36M USD |
| Selling, general, and administrative | 740.27M USD | 690.15M USD | 736.01M USD | 658.03M USD | 626.97M USD |
| Operating expenses | 935.45M USD | 931.83M USD | 943.52M USD | 850.38M USD | 807.63M USD |
| Interest income | 7.39M USD | 17.42M USD | 16.62M USD | 11.02M USD | 12.22M USD |
| Interest expense | 69.55M USD | 89.68M USD | 98.86M USD | 48.8M USD | 44.94M USD |
| Depreciation and amortization | 206.24M USD | 191.83M USD | 165.91M USD | 130.42M USD | 131.68M USD |
| Operating income | 893.22M USD | 826.35M USD | 817.68M USD | 873.4M USD | 821.71M USD |
| Net income | 642.63M USD | 637.83M USD | 642.23M USD | 707.76M USD | 692.84M USD |
Company facts updated Sep 10, 2026.
Recent quarterly results
Recent quarterly results
Third-party consensus; not a GoAI recommendation.
Average target
$438.36
8.29% upside| Action | Ex-dividend date | Details | Record date | Payment date |
|---|---|---|---|---|
Dividend | Nov 26, 1996 | $0.16Irregular | — | — |
Ex-dividend Nov 26, 1996
$0.16
Irregular
AI-generated and delayed market data for informational and educational purposes only. Not investment advice.